High-Throughput Screening Market worth .4 billion by 2025 - Exclusive Report by MarketsandMarkets™

Posted by snehal shaha on September 27th, 2022

The high-throughput screening (HTS) market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market.

The global high-throughput screening (HTS) market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.

Scope of the Report

This report categorizes the high-throughput screening market into the following segments and subsegments:

High-throughput screening Market, by Product & Service

• Consumables
• Reagents & Assay Kits
• ;Laboratory Equipment
• Instruments
• Liquid Handling Systems
• Detection Systems
• Other Instruments
• Services
• Software

High-throughput Screening Market, by Technology

• Cell-based Assays
•  2D Cell Culture
• 3D Cell Culture
• Scaffold-based Technology
• Hydrogels
• Animal-derived Hydrogels
• Matrigel
• Collagen
• Synthetic Hydrogels
• Alginate/Agarose
• Inert Matrix/Solid Scaffolds
• Micropatterned Surfaces
• Scaffold-free Technology
• Ultra-low Binding Plates   
• Hanging-drop Plates
• Other Scaffold-free Technologies
• Reporter-based Assays
• Perfusion Cell Culture
• Lab-on-a-Chip Technology (LOC)
• Label-free Technology

High-throughput Screening Market, by Application

• Drug Discovery
• Biochemical Screening
• Life Sciences Research
• Other Applications

High-throughput Screning Market, by End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Other End Users

High-throughput Screning Market, by Region

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe (RoE)
• Asia Pacific (APAC)
• Japan
• China
• India
• Australia
• Rest of Asia Pacific (RoAPAC)
• Rest of the World (RoW)
• Latin America
• Middle East and Africa

Market Segmentation:

On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis:

In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the market in this region.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top Key Players:-

Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US),  Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).